The Journal of Immunology, Vol 143, Issue 9 2900-2906, Copyright © 1989 by American Association of Immunologists

ARTICLES

Characterization of IL-6 receptor expression by monoclonal and polyclonal antibodies

Y Hirata, T Taga, M Hibi, N Nakano, T Hirano and T Kishimoto
Division of Immunology, Osaka University, Japan.

mAb and polyclonal antibodies against human IL-6R were prepared by using a murine transfectant cell line expressing the human IL-6R and a synthetic oligopeptide made on the basis of the deduced amino acid sequence as immunogens. Immunoprecipitation of radiolabeled IL-6R with these antibodies showed that the Mr of a mature IL-6R was 80 kDa and its value was reduced to 50K after treatment with O- and N-glycanase and neuraminidase, indicating that IL-6R is a glycoprotein. Two mAb recognizing different epitopes were prepared. One, PM1 inhibited the binding of 125I-IL-6 to the receptor and blocked the IL-6-dependent growth of a T lymphoma line, KT3. PM1 could not bind to IL-6R when it was saturated with IL-6, indicating that this antibody recognizes the IL-6 binding or the adjacent site on IL-6R. The other, MT18 was not inhibited by IL-6 for its recognition of IL-6R, therefore, this could be used for cytofluorometric staining of normal cells. Nonstimulated B cells expressed undetectable amount of IL-6R regardless of the expression of surface IgD. However, after the stimulation with PWM, IL- 6R was observed on IgD- B cells with a relatively large size, but subtly on IgD- small B cells and not on IgD+ B cells, fitting the function of IL-6 which acts on activated B cells to induce Ig production. In contrast, IL-6R was detected on non-stimulated CD4+/CD8- and CD4-/CD8+ T cells. The level of IL-6R on both T cell subpopulations was not significantly changed after stimulation with phytohemagglutinin.

This article has been cited by other articles:

				S. Hillion, M. Dueymes, P. Youinou, and C. Jamin IL-6 Contributes to the Expression of RAGs in Human Mature B Cells J. Immunol., November 15, 2007; 179(10): 6790 - 6798. [Abstract] [Full Text] [PDF]

				B. J. Jenkins, A. W. Roberts, C. J. Greenhill, M. Najdovska, T. Lundgren-May, L. Robb, D. Grail, and M. Ernst Pathologic consequences of STAT3 hyperactivation by IL-6 and IL-11 during hematopoiesis and lymphopoiesis Blood, March 15, 2007; 109(6): 2380 - 2388. [Abstract] [Full Text] [PDF]

				H.-H. Oberg, D. Wesch, S. Grussel, S. Rose-John, and D. Kabelitz Differential expression of CD126 and CD130 mediates different STAT-3 phosphorylation in CD4+CD25- and CD25high regulatory T cells Int. Immunol., April 1, 2006; 18(4): 555 - 563. [Abstract] [Full Text] [PDF]

				J. N. Varghese, R. L. Moritz, M.-Z. Lou, A. van Donkelaar, H. Ji, N. Ivancic, K. M. Branson, N. E. Hall, and R. J. Simpson Structure of the extracellular domains of the human interleukin-6 receptor alpha -chain PNAS, December 10, 2002; 99(25): 15959 - 15964. [Abstract] [Full Text] [PDF]

				T. Kimura, J. Wang, H. Minamiguchi, H. Fujiki, S. Harada, K. Okuda, H. Kaneko, S. Yokota, K. Yasukawa, T. Abe, et al. Signal through gp130 Activated by Soluble Interleukin (IL)-6 Receptor (R) and IL-6 or IL-6R/IL-6 Fusion Protein Enhances Ex Vivo Expansion of Human Peripheral Blood-Derived Hematopoietic Progenitors Stem Cells, November 1, 2000; 18(6): 444 - 452. [Abstract] [Full Text]

				X. Sui, K. Tsuji, Y. Ebihara, R. Tanaka, K. Muraoka, M. Yoshida, K. Yamada, K. Yasukawa, T. Taga, T. Kishimoto, et al. Soluble Interleukin-6 (IL-6) Receptor With IL-6 Stimulates Megakaryopoiesis From Human CD34+ Cells Through Glycoprotein (gp)130 Signaling Blood, April 15, 1999; 93(8): 2525 - 2532. [Abstract] [Full Text] [PDF]

				A. R. Cole, N. E. Hall, H. R. Treutlein, J. S. Eddes, G. E. Reid, R. L. Moritz, and R. J. Simpson Disulfide Bond Structure and N-Glycosylation Sites of the Extracellular Domain of the Human Interleukin-6 Receptor J. Biol. Chem., March 12, 1999; 274(11): 7207 - 7215. [Abstract] [Full Text] [PDF]

				C. Renne, K.-J. Kallen, J. Mullberg, T. Jostock, J. Grotzinger, and S. Rose-John A New Type of Cytokine Receptor Antagonist Directly Targeting gp130 J. Biol. Chem., October 16, 1998; 273(42): 27213 - 27219. [Abstract] [Full Text] [PDF]

				O. A. Adebanjo, B. S. Moonga, T. Yamate, L. Sun, C. Minkin, E. Abe, and M. Zaidi Mode of Action of Interleukin-6 on Mature Osteoclasts. Novel Interactions with Extracellular Ca2+ Sensing in the Regulation of Osteoclastic Bone Resorption J. Cell Biol., September 7, 1998; 142(5): 1347 - 1356. [Abstract] [Full Text] [PDF]

				X.-J. Wang, T. Taga, K. Yoshida, M. Saito, T. Kishimoto, and H. Kikutani gp130, The Cytokine Common Signal-Transducer of Interleukin-6 Cytokine Family, Is Downregulated in T Cells In Vivo by Interleukin-6 Blood, May 1, 1998; 91(9): 3308 - 3314. [Abstract] [Full Text] [PDF]

				T. Kimura, H. Sakabe, S. Tanimukai, T. Abe, Y. Urata, K. Yasukawa, A. Okano, T. Taga, H. Sugiyama, T. Kishimoto, et al. Simultaneous Activation of Signals Through gp130, c-kit, and Interleukin-3 Receptor Promotes a Trilineage Blood Cell Production in the Absence of Terminally Acting Lineage-Specific Factors Blood, December 15, 1997; 90(12): 4767 - 4778. [Abstract] [Full Text] [PDF]

				A. YOKOYAMA, N. KOHNO, K. SAKAI, K.-I. KONDO, Y. HIRASAWA, and K. HIWADA Circulating Levels of Soluble Interleukin-6 Receptor in Patients with Bronchial Asthma Am. J. Respir. Crit. Care Med., November 1, 1997; 156(5): 1688 - 1691. [Abstract] [Full Text]

				K. C. Wollert, T. Taga, M. Saito, M. Narazaki, T. Kishimoto, C. C. Glembotski, A. B. Vernallis, J. K. Heath, D. Pennica, W. I. Wood, et al. Cardiotrophin-1 Activates a Distinct Form of Cardiac Muscle Cell Hypertrophy J. Biol. Chem., April 19, 1996; 271(16): 9535 - 9545. [Abstract] [Full Text] [PDF]